References
- Dai D, Balega J, Sundar S, et al. Serum albumin as a predictor of survival after interval debulking surgery for advanced ovarian cancer (AOC): a retrospective study. J Invest Surg. 2020;6:1–6.doi:https://doi.org/10.1080/08941939.2020.1827314.
- Gupta D, Lis CG. Pretreatment serum albumin as a predictor of cancer survival: a systematic review of the epidemiological literature. Nutr J. 2010;9:69. doi:https://doi.org/10.1186/1475-2891-9-69.
- Lv GY, An L, Sun XD, Hu YL, Sun DW. Pretreatment albumin to globulin ratio can serve as a prognostic marker in human cancers: a meta-analysis. Clin Chim Acta. 2018;476:81–91. doi:https://doi.org/10.1016/j.cca.2017.11.019.
- Ayhan A, Günakan E, Alyazıcı İ, Haberal N, Altundağ Ö, Dursun P. The preoperative albumin level is an independent prognostic factor for optimally debulked epithelial ovarian cancer. Arch Gynecol Obstet. 2017;296(5):989–995.
- He X, Li J-P, Liu X-H, et al. Prognostic value of C-reactive protein/albumin ratio in predicting overall survival of Chinese cervical cancer patients overall survival: comparison among various inflammation based factors. J Cancer. 2018;9(10):1877–1884.
- Seebacher V, Grimm C, Reinthaller A, et al. The value of serum albumin as a novel independent marker for prognosis in patients with endometrial cancer. Eur J Obstet Gynecol Reprod Biol. 2013;171(1):101–106.